Pure Bioscience Inc (PURE) CEO Tom Y Lee Bought $351,537 of Shares

Author's Avatar
Jun 18, 2020
Article's Main Image

CEO of Pure Bioscience Inc (30-Year Financial, Insider Trades) Tom Y Lee (insider trades) bought 202,033 shares of PURE on 06/17/2020 at an average price of $1.74 a share. The total cost of this purchase was $351,537.

PURE Bioscience Inc is engaged in developing and commercializing its proprietary antimicrobial products.The firm also contract manufacture and sell silver dihydrogen citrate technology based formulations to manufacturers. PURE Bioscience Inc has a market cap of $158.150 million; its shares were traded at around $1.82 with and P/S ratio of 42.35. PURE Bioscience Inc had annual average EBITDA growth of 30.70% over the past ten years. GuruFocus has detected 2 severe warning signs with PURE Bioscience Inc. .

CEO Recent Trades:

  • CEO Tom Y Lee bought 202,033 shares of PURE stock on 06/17/2020 at the average price of $1.74. The price of the stock has increased by 4.6% since.

For the complete insider trading history of PURE, click here

.